Cargando…
The Current Status, Challenges, and Future Potential of Therapeutic Vaccination in Glioblastoma
Glioblastoma (GBM) is the most common malignant primary brain tumor and confers a dismal prognosis. With only two FDA-approved therapeutics showing modest survival gains since 2005, there is a great need for the development of other disease-targeted therapies. Due, in part, to the profound immunosup...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141140/ https://www.ncbi.nlm.nih.gov/pubmed/37111620 http://dx.doi.org/10.3390/pharmaceutics15041134 |